Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott K Howell

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Annals of the New York Academy of Sciences|July 23, 2005
Transglycation--a potential new mechanism for deglycation of Schiff's basesBenjamin S Szwergold, Scott K Howell, Paul J Beisswenger
Biochimica Et Biophysica Acta|January 16, 2003
Glyceraldehyde-3-phosphate dehydrogenase activity as an independent modifier of methylglyoxal levels in diabetesPaul J Beisswenger, Scott K Howell, Kenneth Smith, et al.
Annals of the New York Academy of Sciences|July 23, 2005
Methylglyoxal can modify GAPDH activity and structureHyon Jae Lee, Scott K Howell, Rebecca J Sanford, et al.
Diabetes Care|September 28, 2005
Glycated and oxidized protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetesNaila Ahmed, Roya Babaei-Jadidi, Scott K Howell, et al.
Amino Acids|September 17, 2013
Detection of diabetic nephropathy from advanced glycation endproducts (AGEs) differs in plasma and urine, and is dependent on the method of preparationPaul J Beisswenger, Scott K Howell, Greg Russell, et al.
Diabetes|October 27, 2005
Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stressPaul J Beisswenger, Keith S Drummond, Robert G Nelson, et al.
Diabetes Care|June 20, 2013
Early progression of diabetic nephropathy correlates with methylglyoxal-derived advanced glycation end productsPaul J Beisswenger, Scott K Howell, Gregory B Russell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 17, 2019
Advanced Glycation End Products Are Associated With Inflammation and Endothelial Dysfunction in HIVVanessa El Kamari, Alicia Thomas, Lingpeng Shan, et al.
Journal of Diabetes and Its Complications|May 1, 2012
Effects on post-prandial glucose and AGE precursors from two initial insulin strategies in patients with type 2 diabetes uncontrolled by oral agentsOlga V Sakharova, Ranee R Lleva, James D Dziura, et al.
Open Forum Infectious Diseases|October 11, 2021
Advanced Glycation End Products Associated With Cardiometabolic Biomarkers in Treated Human Immunodeficiency Virus InfectionVanessa El Kamari, Katherine Rodriguez, Carlee Moser, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Annals of the New York Academy of Sciences|July 23, 2005
Transglycation--a potential new mechanism for deglycation of Schiff's basesBenjamin S Szwergold, Scott K Howell, Paul J Beisswenger
Biochimica Et Biophysica Acta|January 16, 2003
Glyceraldehyde-3-phosphate dehydrogenase activity as an independent modifier of methylglyoxal levels in diabetesPaul J Beisswenger, Scott K Howell, Kenneth Smith, et al.
Annals of the New York Academy of Sciences|July 23, 2005
Methylglyoxal can modify GAPDH activity and structureHyon Jae Lee, Scott K Howell, Rebecca J Sanford, et al.
Diabetes Care|September 28, 2005
Glycated and oxidized protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetesNaila Ahmed, Roya Babaei-Jadidi, Scott K Howell, et al.
Amino Acids|September 17, 2013
Detection of diabetic nephropathy from advanced glycation endproducts (AGEs) differs in plasma and urine, and is dependent on the method of preparationPaul J Beisswenger, Scott K Howell, Greg Russell, et al.
Diabetes|October 27, 2005
Susceptibility to diabetic nephropathy is related to dicarbonyl and oxidative stressPaul J Beisswenger, Keith S Drummond, Robert G Nelson, et al.
Diabetes Care|June 20, 2013
Early progression of diabetic nephropathy correlates with methylglyoxal-derived advanced glycation end productsPaul J Beisswenger, Scott K Howell, Gregory B Russell, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 17, 2019
Advanced Glycation End Products Are Associated With Inflammation and Endothelial Dysfunction in HIVVanessa El Kamari, Alicia Thomas, Lingpeng Shan, et al.
Journal of Diabetes and Its Complications|May 1, 2012
Effects on post-prandial glucose and AGE precursors from two initial insulin strategies in patients with type 2 diabetes uncontrolled by oral agentsOlga V Sakharova, Ranee R Lleva, James D Dziura, et al.
Open Forum Infectious Diseases|October 11, 2021
Advanced Glycation End Products Associated With Cardiometabolic Biomarkers in Treated Human Immunodeficiency Virus InfectionVanessa El Kamari, Katherine Rodriguez, Carlee Moser, et al.
Pageof 1